Topics

Articles

Canada's Rexall chain, plus Biologics, Inc, and Vantage Oncology

New healthcare proposals re-open talk of drug importation

Global drug-wholesaler group plans future educational and developmental work

Outsourced services can provide significant financial and risk-avoidance benefits

The rise in product volume is more than matched by the rise of regulatory constraints

Looking at the essential value of well-managed supply chains

IMS Health/Ego Zender survey of CIOs finds short tenures and evolving skill sets

HDMA seeks to encourage more outreach to business partners and government

'Average Manufacturer Price' is now a mostly settled matter